Cardio Diagnostics Holdings Stock Price on November 23, 2024
| CDIO Stock | USD 0.27 0.02 8.00% |
If you're considering investing in Cardio Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cardio Diagnostics stands at 0.27, as last reported on the 23rd of November, with the highest price reaching 0.27 and the lowest price hitting 0.24 during the day. Cardio Diagnostics secures Sharpe Ratio (or Efficiency) of -0.0251, which signifies that the company had a -0.0251% return per unit of risk over the last 3 months. Cardio Diagnostics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cardio Diagnostics' Risk Adjusted Performance of (0.03), standard deviation of 9.31, and Mean Deviation of 6.15 to double-check the risk estimate we provide.
At this time, Cardio Diagnostics' Other Stockholder Equity is very stable compared to the past year. As of the 23rd of November 2024, Stock Based Compensation is likely to grow to about 1.3 M, while Total Stockholder Equity is likely to drop about 2.3 M. . As of the 23rd of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.07, while Price To Sales Ratio is likely to drop 1,758. Cardio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cardio |
Sharpe Ratio = -0.0251
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CDIO |
Estimated Market Risk
| 9.5 actual daily | 84 84% of assets are less volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cardio Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardio Diagnostics by adding Cardio Diagnostics to a well-diversified portfolio.
Price Book 2.7141 | Enterprise Value Ebitda (22.48) | Price Sales 255.629 | Shares Float 20.8 M | Wall Street Target Price 2 |
Cardio Diagnostics Valuation on November 23, 2024
It is possible to determine the worth of Cardio Diagnostics on a given historical date. On November 23, 2024 Cardio was worth 0.24 at the beginning of the trading date compared to the closed value of 0.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardio Diagnostics stock. Still, in general, we apply an absolute valuation method to find Cardio Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardio Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardio Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 0.24 | 0.27 | 0.23 | 0.25 | 1,077,427 | |
11/22/2024 | 0.24 | 0.27 | 0.24 | 0.27 | 516,329 |
| Backtest Cardio Diagnostics | | | Cardio Diagnostics History | | | Cardio Diagnostics Valuation | Previous |
Cardio Diagnostics Trading Date Momentum on November 23, 2024
| On November 22 2024 Cardio Diagnostics Holdings was traded for 0.27 at the closing time. The top price for the day was 0.27 and the lowest listed price was 0.24 . The trading volume for the day was 516.3 K. The trading history from November 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 11.11% . |
Cardio Diagnostics Fundamentals Correlations and Trends
By evaluating Cardio Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cardio Diagnostics Stock history
Cardio Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardio Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardio Diagnostics stock prices may prove useful in developing a viable investing in Cardio Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.7 M | 7.3 M | |
| Net Loss | -558.4 K | -586.3 K |
Cardio Diagnostics Quarterly Net Working Capital |
|
Cardio Diagnostics Stock Technical Analysis
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cardio Diagnostics Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Cardio Diagnostics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cardio Diagnostics November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By undertsting and applying Cardio Diagnostics stock market strength indicators, traders can identify Cardio Diagnostics Holdings entry and exit signals to maximize returns
Cardio Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardio Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Cardio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.68) | |||
| Treynor Ratio | (0.1) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.